Sibold William John Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$2.08M

Insider Activity of Sibold William John

According to the SEC Form 4 filings, Sibold William John, being in a position of

  1. President and CEO at Madrigal Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 19723 shares for $10.48M,
    over all time since 2024-09-09, has bought 0 shares, and sold 42565 shares for $18.86M.

Biography of Sibold William John

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $10,483,1306100

Comparison of Insiders on Amount of Buys and Sells

2026-09-11SaleMadrigal Pharmaceuticals, Inc.
MDGL
President and CEO
5,221
0.0229%
$542.39$2.83M-10.77%
2026-09-09SaleMadrigal Pharmaceuticals, Inc.
MDGL
President and CEO
6,362
0.027%
$535.59$3.41M-10.78%
2026-07-20SaleMadrigal Pharmaceuticals, Inc.
MDGL
President and CEO
2,500
0.0107%
$547.30$1.37M-4.2%
2026-03-06SaleMadrigal Pharmaceuticals, Inc.
MDGL
President and CEO
1,663
0.0073%
$431.94$718,316+18.78%
2026-01-26SaleMadrigal Pharmaceuticals, Inc.
MDGL
President and CEO
1,577
0.0068%
$492.42$776,546+2.53%
2025-12-04SaleMadrigal Pharmaceuticals, Inc.
MDGL
President and CEO
2,400
0.0106%
$575.34$1.38M-12.49%
2025-09-09SaleMadrigal Pharmaceuticals, Inc.
MDGL
President and CEO
7,279
0.0324%
$445.63$3.24M+14.06%
2025-08-21SaleMadrigal Pharmaceuticals, Inc.
MDGL
President and CEO
7,616
0.0336%
$400.18$3.05M+24.13%
2025-01-24SaleMadrigal Pharmaceuticals, Inc.
MDGL
President and CEO
1,584
0.0074%
$335.24$531,020+4.67%
2024-09-09SaleMadrigal Pharmaceuticals, Inc.
MDGL
President and CEO
6,363
0.0299%
$243.83$1.55M+31.09%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.